Philadelphia, PA, May 18, 2017 --(PR.com
)-- More than 200 leaders in healthcare and technology joined together for the 2017 Heart Science Forum in Philadelphia to address the aims of the American Heart Association’s 2020 Impact Goal: to improve the cardiovascular health of all Americans by 20 percent while reducing death from cardiovascular diseases and stroke by 20 percent by the year 2020. Competitors in the AHA Heart Innovation Forum Challenge (philadelphiaheartscienceforum.com) were evaluated on scientific and technical merit, innovativeness, readiness, the potential to scale to serve the U.S. population, and potential impact. Presented by Emergency MCG’s Dr. Leigh Mack, the Multifunction Cardiogram won the Forum’s People’s Choice innovation award by popular audience vote.
Approximately 1 in 4 deaths in the United States are attributable to heart disease, and for many patients suffering a major adverse coronary event (MACE) such as a heart attack, there are no symptoms of heart disease until it reaches life-threatening levels. The MCG is a desperately-needed noninvasive technology which brings a new level of accuracy and speed for identifying even the earliest stages of conditions affecting the heart or cardiovascular system. The MCG introduces machine-learning, cloud-based, quantitative engineering models to provide completely objective, consistent results in under 15 minutes and for less than $300 per test. The MCG is also the first in a new class of hardware cardiovascular instruments that leverages big data, cloud computing, and automated classification techniques aiding diagnosticians in the highly accurate detection of heart disease. The MCG represents a new generation of technologies that addresses the shortcomings of existing cardiovascular diagnostic tools.
The MCG addresses a huge challenge facing US healthcare – patients presenting to emergency rooms with chest pain, by offering an expedient and inexpensive bedside cardiovascular diagnostic that is exceptionally accurate. Coupled with lifestyle, nutrition, fitness, and stress management programs, the MCG can provide unprecedented support for identification, monitoring, control, and reversal of heart disease before it becomes life threatening for millions of Americans.
About Emergency MCG:
Emergency MCG Inc. is a medical device and diagnostic services company which saves lives through accurate, early, noninvasive, and inexpensive measurement of heart disease. We accomplish this via the Multifunction CardioGram (MCG) – the most accurate cardiovascular disease detection technology available as a non-invasive, mobile aid to diagnosis.